Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2023-02-24 00:00:00 ET · period of report 2023-02-22 · accession 0001209191-23-012679 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-24 | 2023-02-22 | DLB | Pendleton Todd | SVP, CMO | S - Sale+OE | $82.32 | -28.7K | 38.6K | -43% | -$2.36M |
| DM | 2023-02-24 | 2023-02-22 | DLB | Pendleton Todd | SVP, CMO | M - OptEx | $65.62 | +18.4K | 54.1K | +51% | +$1.21M |
| DM | 2023-02-24 | 2023-02-22 | DLB | Pendleton Todd | SVP, CMO | M - OptEx | $0.00 | -18.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-02-22 | S | D | 28,701 | $82.32 | 38,580 | D | — | — | (F2) The shares were sold in multiple transactions at prices ranging from $81.95 to $82.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. (F1) Shares held following the reported transactions include 34,670 restricted stock units, which are subject to forfeiture until they vest |
| 2 | Common | Class A Common Stock | 2023-02-22 | M | A | 7,927 | $68.40 | 67,281 | D | — | — | (F1) Shares held following the reported transactions include 34,670 restricted stock units, which are subject to forfeiture until they vest |
| 3 | Common | Class A Common Stock | 2023-02-22 | M | A | 5,209 | $62.43 | 59,354 | D | — | — | (F1) Shares held following the reported transactions include 34,670 restricted stock units, which are subject to forfeiture until they vest |
| 4 | Common | Class A Common Stock | 2023-02-22 | M | A | 5,250 | $64.60 | 54,145 | D | — | — | (F1) Shares held following the reported transactions include 34,670 restricted stock units, which are subject to forfeiture until they vest |
| 5 | Derivative | Employee Stock Option (right to buy) | 2023-02-22 | M | D | 7,927 | $0.00 | 8,808 | D | $68.40 · — to 2029-12-16 | 7,927 Class A Common Stock | (F5) This option was granted for a total of 42,275 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2023-02-22 | M | D | 5,250 | $0.00 | 0 | D | $64.60 · — to 2028-12-17 | 5,250 Class A Common Stock | (F3) This option was granted for a total of 36,000 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2023-02-22 | M | D | 5,209 | $0.00 | 0 | D | $62.43 · — to 2028-07-16 | 5,209 Class A Common Stock | (F4) This option was granted for a total of 125,000 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. |